LifeNet Health(R) Unveils New Biomedical Spine Implant

Mon Mar 3, 2008 10:22am EST

* Reuters is not responsible for the content in this press release.

VIRGINIA BEACH, Va., March 3 /PRNewswire-USNewswire/ -- LifeNet Health, a
leading allograft bio-implant company, unveils the VertiGraft VG1(R) Cervical
Bio-implant. This product has been engineered for anterior cervical fusion
surgery to treat neck pain and cervical pathologies.

The new VG1(R) Cervical Bio-implant was co-developed by LifeNet Health and
DePuy Spine(TM), and is exclusively represented in the U.S. by DePuy Spine.

"VG1(R) Cervical is an exciting addition to our VertiGraft spine specialty
bio-implant portfolio. Many surgery centers and hospitals do not have access
to the ultra low-temperature freezers needed to store frozen allograft. VG1
Cervical is freeze-dried so it can be stored at room temperature giving our
customers convenient, room-temperature storage combined with the very high
quality standards they demand. This new VG1(R) Cervical bio-implant will meet
the surgeon's needs and benefit the patient by making very high quality
allograft bio-implants available to more hospitals and surgery centers," says
Michael Hobert, LifeNet Health's VertiGraft Product Manager.

LifeNet Health's CEO Rony Thomas states, "LifeNet Health's VertiGraft
portfolio is setting the standard in spine specialty allograft bio-implants.
Our research and development teams have engineered this implant to provide the
patient and the surgeon with the bio-implants they need. We want to maximize
the chances of successful transplantation and we are proud to be able to
provide the VG1(R) Cervical bio-implant as a solution."

LifeNet Health will exhibit the company's bio-implants at this year's American
Academy of Orthopaedic Surgeons (AAOS) meeting, to be held in San Francisco
March 5th through 8th. At AAOS, LifeNet Health will officially unveil the new
VertiGraft VG1(R) Cervical. The LifeNet Health exhibit booth at the AAOS
Annual Meeting in San Francisco will give surgeons a chance to learn more
about LifeNet Health's product lines, its outstanding safety record and its
unyielding commitment to quality. Since 1995, LifeNet Health has distributed 1
million bio-implants with no incidence of disease transmission linked to
tissue screened and processed using LifeNet Health's proprietary Allowash
XG(R) technology. "Surgeons can depend on us. We offer high-quality, safe
bio-implants to save lives and restore health," adds Thomas.

LifeNet Health, founded in 1982, is a full service biomedical tissue banking
system and a leading non-profit organ and tissue donation agency whose mission
is saving lives and restoring health. LifeNet Health provides recovery and
processing services for musculoskeletal and cardiovascular tissues,
distributing more than 250,000 biomedical implants every year to restore
health to patients around the world.

For additional information about LifeNet Health, visit

CONTACT:  Dena Reynolds of LifeNet, 1-800-847-7831


Dena Reynolds of LifeNet, +1-800-847-7831
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.